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Abstract
Background: GPs can use the C- reactive protein (CRP) point- of- care test (POCT) to assist when 
deciding whether to prescribe antibiotics for patients with acute respiratory tract infections (RTIs).
Aim: To estimate the CRP cut- off levels that Danish GPs use to guide antibiotic prescribing for patients 
presenting with different signs and symptoms of RTIs.
Design & setting: A cross- sectional study conducted in general practice in Denmark.
Method: During the winters of 2017 and 2018, 143 GPs and their staff registered consecutive patients 
with symptoms of an RTI according to the Audit Project Odense (APO) method. CRP cut- offs were 
estimated as the lowest level at which half of the patients were prescribed an antibiotic.
Results: In total, 7813 patients were diagnosed with an RTI, of whom 4617 (59%) had a CRP test 
performed. At least 25% of the patients were prescribed an antibiotic when the CRP level was >20 
mg/L, at least 50% when CRP was >40 mg/L, and at least 75% when CRP was >50 mg/L. Lower 
thresholds were identified for patients aged ≥65 years and those presenting with a fever, poor general 
appearance, dyspnoea, abnormal lung auscultation, or ear/facial pain, and if the duration of symptoms 
was either short (≤1 day) or long (>14 days).
Conclusion: More than half of patients presenting to Danish general practice with symptoms of an 
RTI have a CRP test performed. At CRP levels >40 mg/L, the majority of patients have an antibiotic 
prescribed.
How this fits in
For more than 20 years, GPs in Denmark have been paid a fee for performing a CRP test. No specific 
CRP cut- off level exists when using CRP to assist decisions on whether to prescribe antibiotics for 
patients with an RTI, and GPs are encouraged to always evaluate the result in combination with 
careful history taking and a physical examination.
This study shows that more than half of patients attending Danish general practice with 
symptoms of an acute RTI have a CRP test performed, and 40 mg/L is the CRP- level above which 
the majority of patients have an antibiotic prescribed. That level varies substantially with the 
patients’ age, signs, and symptoms indicating that CRP results are evaluated in the context of 
other information.
Lykkegaard J et al. BJGP Open 2021; DOI: 10.3399/bjgpopen20X101136
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Introduction
CRP is a marker of inflammation that can be measured quickly in general practice as a POCT.1,2 
The level of CRP ranges from around 2 mg/L in healthy patients to as high as 500 mg/L in patients 
with a severe inflammatory response.3 The role of CRP POCT in distinguishing bacterial from viral 
infections in general practice is much debated.4–6 An elevated CRP level (>20 mg/L) is associated 
with having an infiltrate on a chest radiograph.7–9 Furthermore, elevated CRP levels have been 
associated with the diagnosis of maxillary sinusitis10 and with benefits from antibiotic treatment 
in patients with exacerbation of chronic obstructive pulmonary disease.11 However, a systematic 
review concluded that CRP POCT was not sufficiently sensitive to rule out, nor sufficiently specific 
to rule in, a bacterial lower RPI.12
GPs in many countries use CRP POCT to assist when deciding whether to prescribe antibiotics 
for patients with acute RPIs. Use of CRP POCT in general practice can reduce antibiotic prescription 
and thereby help slow down the worrying rise in antibiotic resistant bacteria.13–17 The use of CRP 
POCT is expected to rapidly increase globally.18
Most randomised trials on the effects of introducing CRP POCT in general practice have used 
the recommendations not to prescribe antibiotics if CRP is <20 mg/L, and to prescribe antibiotics 
if CRP ≥100 mg/L.15,17,19–21 In addition, some of the trials recommended withholding antibiotics in 
most cases if CRP <50 mg/L.17,19–21 Guidelines in most countries, including the UK, the Netherlands, 
and the Scandinavian countries, tend to follow these recommendations.22–24
Around 20% of CRP test results range from 20 to 99 mg/L, where they offer limited assistance to 
the GP.15,19 There is little knowledge on how GPs in their daily practice interpret these intermediate 
levels of CRP and overcome the dilemma about when to prescribe antibiotics. For more than 20 
years, the GPs in Denmark have been paid a fee for performing a CRP POCT, and virtually all 
Danish general practices use CRP on a daily basis. This study aimed to estimate which CRP cut- off 
levels Danish GPs use to guide antibiotic prescribing for patients presenting with different signs 
and symptoms of acute RPIs.
Method
Design
All GPs and practice staff in the northern, southern, and central regions of Denmark were invited 
to register all consecutive consultations in which the patient presented with symptoms of an acute 
RPI. Healthcare professionals registered patients during four weeks in the winters of 2017 or 2018.
Setting
Denmark has 5.8 million citizens, 54% living in the three study regions. In Denmark, family medicine 
is a specialty in line with other medical specialties. To become a GP, it requires authorisation from 
the Danish Board of Health based on 5 years of specialist training and courses. GPs manage the 
vast majority of patients with acute RTIs and act as gatekeeper to secondary care treatment. GPs 
are self- employed, working on a contract with the public funder. Nearly all services to the patients 
are tax paid. The GPs receive a capitation fee and fees for services, including a fee for measuring 
CRP (€9), paying for the test equipment themselves. All antibiotics are on prescription only. The 
use of antibiotics in Denmark is below the EU average.25
Data
Data were collected by means of a simple registration chart provided by APO (Supplementary Figure 
1). For each patient, the healthcare professional registered symptoms, duration, if a deterioration 
occurred, findings, the level of CRP (if measured), and if antibiotics were prescribed.
Analysis
Descriptive statistics and age- adjusted logistic regression were used to analyse associations between 
patient characteristics and whether a CRP POCT was performed.
For each level of CRP, the proportion of patients who were prescribed an antibiotic was calculated 
based on the patients who had a CRP level in the range of 5 mg/L below the level to 5 mg/L above. 
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Based on binomial distribution, 95% confidence intervals (CI) were calculated for each level of CRP. 
The CRP cut- off level for prescribing antibiotics was defined as the lowest level at which at least half 
of the patients were prescribed an antibiotic. The authors performed sensitivity analyses using ranges, 
0 mg/L and 10 mg/L below and above the index CRP level, respectively (Figure 1). All analyses were 
performed in STATA Release 15 (STATACorp, College Station, TX, USA).
Results
A total of 143 GPs participated in the study; 20% of all GPs in the northern, 6% in the southern, and 
5% in the central region of Denmark (Table 1). The GPs and practice staff registered a total of 8232 
patients diagnosed with an acute RTI. After removing patients with missing information on CRP or 
Figure 1 C- reactive protein (CRP) levels and the proportion of patients prescribed an antibiotic. Legends indicate the width of the interval around 
the index CRP level used to calculate the proportion of patients who were prescribed antibiotics, respectively 0, 5, and 10mg/L above and below. Bars 
indicate 95% confidence intervals. CRP levels 150–300mg/L not shown.
Table 1 Characteristics of the 143 participating GPs compared to all GPs in each regions.
Northern region, n (%) Southern region, n (%) Central region, n (%)
  All GPsa Participants All GPsa Participants All GPsa Participants
Total 303 59 (20) 785 46 (5.9) 811 38 (4.7)
Mean age, years 54 49 59 49 52 51
Female GPs 134 (44) 35 (59) 385 (49) 30 (65) 427 (53) 24 (63)
aNumbers from the Organisation of General Practitioners32
Lykkegaard J et al. BJGP Open 2021; DOI: 10.3399/bjgpopen20X101136
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antibiotics, the study population comprised 7832 patients, of whom 4635 (59%) had a CRP POCT 
performed.
CRP POCT was more often performed on patients presenting with dyspnoea (78%, odds ratio (OR) 
1.97 [95% CI = 1.63 to 2.36]), cough (66%, OR 2.85 [95% CI = 2.54 to 3.20]), or an abnormal lung 
auscultation (72%, OR 1.67 [95% CI = 1.42 to 1.97]) than on patients with a sore throat (56%, OR 0.78 
[95% CI = 0.69 to 0.88]) or ear/facial pain (45%, OR 0.54 [95% CI = 0.47 to 0.62]). Furthermore, having 
a CRP POCT performed was associated with increasing age and patients presenting with a fever, 
deterioration of symptoms, or being assessed with a poor general appearance (Table 2).
The quarter of GP clinics with the highest use of CRP POCT each tested >71% of their patients 
and prescribed antibiotics to 27%, while the quarter of clinics with the lowest use of CRP POCT 
tested <52% of their patients and prescribed antibiotics to 29%.
Among the patients who had a CRP POCT, at least 25% were prescribed an antibiotic when the CRP 
level was >20 mg/L (95% CI = 18 to 22 mg/L), at least 50% when CRP was >40 mg/L (95% CI = 37 to 
42 mg/L), and at least 75% when CRP was >50 mg/L (95% CI = 47 to 98 mg/L). These CRP levels varied 
only little when changing the width of the CPR intervals used to estimate the antibiotics prescription 
proportions (Figure 1). Lower thresholds were identified for patients aged ≥65 years and those presenting 
with a fever, poor general appearance, dyspnoea, abnormal lung auscultation, or ear/facial pain, and if 
the duration of symptoms was either short (≤1 day) or long (>14 days) (Table 3 and Figure 2).
Table 2 C- reactive protein (CRP) tests for patients with acute respiratory tract infections in Danish 
general practice
Patient characteristics
Total CRP POCT performed Odds of CRP POCT
n (%) n (%) ORage- adjusted (95% CI)
Total 7832 (100) 4635 (59)
Age groups, years
0–14 2705 (35) 772 (29) 1 (reference)
15–64 3793 (49) 2773 (73) 6.81 (6.10 to 7.60)
>64 1305 (17) 1071 (82) 11.46 (9.72 to 13.51)
Symptoms and findings
Fever 2971 (38) 1811 (61) 1.81 (1.62 to 2.02)
Cough 5611 (72) 3714 (66) 2.85 (2.54 to 3.20)
Sore throat 1866 (24) 1053 (56) 0.78 (0.69 to 0.88)
Ear/face pain 1317 (17) 592 (45) 0.54 (0.47 to 0.62)
Dyspnoea 881 (11) 691 (78) 1.97 (1.63 to 2.36)
Purulent rhinorrhoea 1324 (17) 714 (54) 0.83 (0.72 to 0.94)
Deterioration of symptoms 861 (11) 569 (66) 1.34 (1.13 to 1.58)
Poor general appearance 1546 (21) 1131 (73) 2.15 (1.87 to 2.47)
Abnormal lung auscultation 1063 (14) 765 (72) 1.67 (1.42 to 1.97)
Duration of symptoms, days
≤1 504 (7) 193 (38) 1 (reference)
2–4 2958 (40) 1551 (52) 1.35 (1.09 to 1.68)
5–14 3233 (44) 2134 (66) 1.85 (1.49 to 2.30)
>14 679 (9) 470 (69) 1.60 (1.22 to 2.09)
CI = confidence interval. CRP = C- reactive protein. OR = odds ratio. POCT = point- of- care test
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Discussion
Summary
A total of 59% of patients attending Danish general practice with symptoms of an acute RTI had a 
CRP test performed. No use of any strict CRP cut- off level for antibiotic prescribing was identified. 
However, at least half of the patients were prescribed an antibiotic when the level was >40 mg/L. The 
GPs’ interpretation of the CRP levels depended on the patient’s age, symptoms, and signs. Lower 
CRP thresholds were identified for older patients and those presenting with a fever, poor general 
appearance, dyspnoea, abnormal lung auscultation, or ear/facial pain, and if the duration of symptoms 
was short (≤1 day) or long (>14 days).









All the patients (n = 4635) 20 (18 to 22) 40 (37 to 42) 50 (47 to 98)
Age group, years
0–14 22 (18 to 67) 43 (32 to 98) 45 (43 to 98)
15–64 22 (20 to 28) 42 (38 to 45) 64 (49 to 99)
>64 17 (14 to 20) 33 (24 to 41) 46 (41 to 98)
Fever
Yes 20 (17 to 23) 38 (34 to 41) 47 (45 to 84)
No 22 (17 to 25) 45 (36 to 97) 66 (50 to 99)
Symptoms
Cough 24 (22 to 27) 42 (38 to 44) 64 (49 to 99)
Sore throat 29 (19 to 37) 45 (38 to 71) 74 (49 to 99)
Ear/face pain 11 (5 to 12) 20 (14 to 99) 40 (37 to 99)
Dyspnoea 11 (8 to 20) 24 (21 to 99) 38 (30 to 99)
Purulent rhinorrhoea 14 (13 to 32) 38 (25 to 99) 55 (40 to 99)
Duration of symptoms, days
≤1 21 (14 to 89) 29 (22 to 99) 53 (29 to 99)
2–4 24 (20 to 36) 43 (41 to 48) 54 (49 to 98)
5–14 17 (15 to 22) 38 (33 to 61) 46 (45 to 99)
>14 15 (14 to 93) 27 (21 to 93) 50 (29 to 93)
Deterioration of symptoms
Yes 14 (11 to 39) 42 (20 to 99) 46 (42 to 99)
No 22 (20 to 24) 41 (37 to 44) 51 (49 to 98)
Poor general appearance
Yes 15 (11 to 17) 29 (22 to 41) 44 (42 to 85)
No 24 (21 to 29) 43 (39 to 46) 66 (51 to 99)
Abnormal lung auscultation
Yes 3 (1 to 8) 22 (13 to 27) 32 (28 to 99)
No 24 (21 to 33) 45 (42 to 62) 68 (50 to 99)
aEstimated as the lowest level of CRP at which the given percentage of patients were prescribed an antibiotic. 
Values in brackets indicate the 95% CI for the CRP levels ±5 mg/L, based on binomial distribution. CI = 
confidence interval. CRP = C- reactive protein.
Lykkegaard J et al. BJGP Open 2021; DOI: 10.3399/bjgpopen20X101136
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Figure 2 Proportions of patients who are prescribed an antibiotic according to C- reactive protein (CRP) levels in the range from 5 mg/L below to 5 mg/L 
above the index. CRP levels 100–300 mg/L not shown.
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Strengths and limitations
Fewer than one in 10 eligible GPs participated in the study. It is likely that these GPs are more interested 
in the management of patients with acute RTIs and thus differ in the use and interpretation of CRP 
tests compared to the non- participants. Furthermore, Danish GPs have a lower antibiotic prescription 
rate and a longer tradition for the use of CRP tests compared to GPs in many other countries.25 
Consequently, the identified cut- off CRP levels are likely to be different if studied in another country.
As demonstrated the CRP cut- off estimates depend heavily on the case- mix, for example, patient 
age, symptoms, and signs. The participating healthcare professionals were asked to consecutively 
include all patients with symptoms of an acute RTI making selection in the GP surgery less likely. 
However, local incidence rates of the different acute RTIs at the time of the study and the patients’ 
doctor- seeking behaviour strongly influence the type of patients included. If fewer mild cases presented 
in the GP surgery, the proportion of severe cases would increase, and probably also the proportion 
of patients having a CRP tests performed and being prescribed an antibiotic. More important to the 
study aim, inclusion of more patients with any of the characteristics associated with a low cut- off 
threshold would lower both the overall threshold estimate and the thresholds found in patients with 
all other characteristics.
The GPs reported 6% of the patients to have explicitly asked for a POCT, but the registration chart 
did not distinguish between asking for a CRP or a streptococcus A rapid test.
Lastly, the cross- sectional design impairs all interpretations of causality. Decisions to record a 
symptom or finding may be influenced by the measured CRP level or a prior decision on whether to 
prescribe an antibiotic. Still, the risk of information bias was considered low since Danish GPs and 
practice staff are familiar with the APO template and made the recordings for their own voluntary 
quality improvement purposes.
Comparison with existing literature
Many guidelines exist on when to prescribe antibiotics according to the CRP level for patients with 
acute RTIs. Most agree that if the CRP level is <20 mg/L antibiotics should not be prescribed. However, 
"the upper value" in support of antibiotic treatment differ between guidelines. Importantly, most 
studies on the use of CRP tests in patients with acute RTIs have been performed in patients with acute 
cough, and solid evidence is lacking for its use in patients with other infections.26
Qualitative studies have identified that GPs request guidance on the interpretation of CRP 
values.27,28 The Danish College of General Practitioners’ guideline for managing patients with acute 
RTIs state that if the CRP value is >50 mg/L, antibiotics should be considered.24 The present study 
indicates that Danish GPs align with that recommendation.
Both national and international guidelines highlight that the result of a CRP test always must be 
evaluated together with the patient history and examination. However, in Scandinavia CRP POCT is 
increasingly used29,30 and sometimes performed even before the patient has been assessed clinically 
(Bisgaard et al, unpublished data, 2021). This may explain why compared to being assessed with 
an abnormal lung auscultation, the symptom “cough” was closer associated with having a CRP 
POCT performed. In the worst case, overuse of the CRP test can result in diagnostic uncertainty and 
consequently lead to an overuse of antibiotics.31
A recent editorial by Cals and Ebell discussed how the CRP test might be incorporated into clinical 
decision rules by combining the test result with symptoms and findings.26 Correspondingly, the 
authors found that older patients and those with a fever, dyspnoea, abnormal lung auscultation, ear/
facial pain, and those with a poor general appearance were prescribed antibiotics at lower CRP levels 
than other patients.
Implications for research and practice
Antibiotic use is the main driver of antimicrobial resistance. Solid evidence exists that use of CRP 
POCT can reduce antibiotic prescribing for acute RTIs. This study found that more than half of the 
patients had a CRP test performed. This was even among those presenting with a sore throat, where 
the streptococcus A rapid test is recommended rather than the CRP POCT.23 Many of the patients 
with a sore throat had other symptoms, as well, and having the sore throat reduced their chance of 
having a CRP POCT performed. Nevertheless, these findings suggest a substantial overuse of CRP 
POCT in Denmark.
Lykkegaard J et al. BJGP Open 2021; DOI: 10.3399/bjgpopen20X101136
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Perhaps now the field has reached a time where future studies need to focus less on the CRP 
tests’ ability to reduce antibiotic prescribing, and more on when the test is indicated and how the 
test results are interpreted. No prior observation studies have investigated how CRP cut- off levels 
are applied in daily clinical practice. The presented CRP levels are useful as a reference for GPs in 
Denmark, and other countries, while waiting for evidence- based algorithms integrating CRP levels 
with signs and symptoms in guiding antibiotic prescriptions.
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